Search

Your search keyword '"Soares, Andreimar M."' showing total 42 results

Search Constraints

Start Over You searched for: Author "Soares, Andreimar M." Remove constraint Author: "Soares, Andreimar M." Topic snake venoms Remove constraint Topic: snake venoms
42 results on '"Soares, Andreimar M."'

Search Results

1. Therapeutic applications of snake venoms: An invaluable potential of new drug candidates.

2. Catalytically Active Snake Venom PLA 2 Enzymes: An Overview of Its Elusive Mechanisms of Reaction.

3. Synergism of in vitro plasmodicidal activity of phospholipase A2 isoforms isolated from panamanian Bothrops asper venom.

4. Engineering of single-domain antibodies for next-generation snakebite antivenoms.

5. Gallic acid anti-myotoxic activity and mechanism of action, a snake venom phospholipase A 2 toxin inhibitor, isolated from the medicinal plant Anacardium humile.

6. Structural, enzymatic and pharmacological profiles of AplTX-II - A basic sPLA 2 (D49) isolated from the Agkistrodon piscivorus leucostoma snake venom.

7. Secondary hemostasis studies of crude venom and isolated proteins from the snake Crotalus durissus terrificus.

8. Isolation, Biochemical Characterization and Antiparasitic Activity of BmatTX-IV, A Basic Lys49-Phospholipase A2 from the Venom of Bothrops mattogrossensis from Paraguay.

9. Photobiomodulation of local alterations induced by BthTX-I, a phospholipase A 2 myotoxin from Bothrops jararacussu snake venom: In vivo and in vitro evaluation.

10. Anti-platelet aggregation activity of two novel acidic Asp49-phospholipases A 2 from Bothrops brazili snake venom.

11. Snake Venom, A Natural Library of New Potential Therapeutic Molecules: Challenges and Current Perspectives.

12. An Update on Potential Molecular Mechanisms Underlying the Actions of Snake Venom L-amino Acid Oxidases (LAAOs).

13. Cross-reactivity and inhibition myotoxic effects induced by Bothrops snake venoms using specific polyclonal anti-BnSP7 antibodies.

14. Mechanism of the cytotoxic effect of l-amino acid oxidase isolated from Bothrops alternatus snake venom.

15. A novel synthetic quinolinone inhibitor presents proteolytic and hemorrhagic inhibitory activities against snake venom metalloproteases.

16. Antitumoral Potential of Snake Venom Phospholipases A2 and Synthetic Peptides.

17. Snake venom L-amino acid oxidases: trends in pharmacology and biochemistry.

18. Activation of J77A.1 macrophages by three phospholipases A2 isolated from Bothrops atrox snake venom.

19. Antitumoral activity of snake venom proteins: new trends in cancer therapy.

20. Purification and biochemical characterization of three myotoxins from Bothrops mattogrossensis snake venom with toxicity against Leishmania and tumor cells.

21. Biochemical characterization, action on macrophages, and superoxide anion production of four basic phospholipases A2 from Panamanian Bothrops asper snake venom.

22. Evaluation of the genotoxicity of Crotalus durissus terrificus snake venom and its isolated toxins on human lymphocytes.

23. Crystallization and preliminary X-ray diffraction studies of BmooPLA2-I, a platelet-aggregation inhibitor and hypotensive phospholipase A2 from Bothrops moojeni venom.

24. Antitumor effects of snake venom chemically modified Lys49 phospholipase A2-like BthTX-I and a synthetic peptide derived from its C-terminal region.

25. Crotalus durissus collilineatus venom gland transcriptome: analysis of gene expression profile.

26. Snake venom phospholipases A2: a new class of antitumor agents.

27. Snake venom L-amino acid oxidases: some consideration about their functional characterization.

28. Crystal structure of a myotoxic Asp49-phospholipase A2 with low catalytic activity: Insights into Ca2+-independent catalytic mechanism.

29. Triterpenoid saponins, new metalloprotease snake venom inhibitors isolated from Pentaclethra macroloba.

30. Snake venom phospholipase A2 inhibitors: medicinal chemistry and therapeutic potential.

31. Antiophidian properties of the aqueous extract of Mikania glomerata.

32. Anticoagulant and antifibrinogenolytic properties of the aqueous extract from Bauhinia forficata against snake venoms.

33. Medicinal plants with inhibitory properties against snake venoms.

34. Chemical modifications of phospholipases A2 from snake venoms: effects on catalytic and pharmacological properties.

35. Anti-snake venom activities of extracts and fractions from callus cultures of Sapindus saponaria.

36. Crystallization and preliminary X-ray diffraction analysis of a Lys49-phospholipase A2 complexed with caffeic acid, a molecule with inhibitory properties against snake venoms.

37. Crystallization and preliminary X-ray diffraction studies of BmooPLA2-I, a platelet-aggregation inhibitor and hypotensive phospholipase A2 from Bothrops moojeni venom.

38. BmajPLA2-II, a basic Lys49-phospholipase A2 homologue from Bothrops marajoensis snake venom with parasiticidal potential.

39. BjussuSP-I: A new thrombin-like enzyme isolated from Bothrops jararacussu snake venom

40. Neutralization of snake venom phospholipase A2 toxins by aqueous extract of Casearia sylvestris (Flacourtiaceae) in mouse neuromuscular preparation

41. Antihemorrhagic, antinucleolytic and other antiophidian properties of the aqueous extract from Pentaclethra macroloba

42. Inhibition of enzymatic and pharmacological activities of some snake venoms and toxins by Mandevilla velutina (Apocynaceae) aqueous extract

Catalog

Books, media, physical & digital resources